NOVABLOC™ NEWS
December 2024
Synaptrix Announces Second Close of Series A, Securing an Additional $13M to Accelerate Development of NOVABLOC™, a drug-free solution for post-surgical pain management and elimination of opioids
May 2025
New Study Demonstrates NOVABLOC™ Provides Up to 20 Days of Continuous Postoperative Pain Relief After Knee Replacement Surgery
Innovative radiofrequency-based neuromodulation technology enables mobility-preserving pain relief with limited opioid use